Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02510430 · ClinicalTrials.gov registry record · NA

The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors

A NA study, sponsored by University of Wisconsin, Madison.

Completed
Registry status
NA
Development phase
59
Enrollment target

NCT02510430 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 59 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02510430, a NA study, has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
NA
Development phase
59 participants
Enrollment target

Study Summary

Excessive sitting time (sedentary time) has been associated with risk of insulin resistance and other factors which may be relevant to breast cancer prognosis. This 8-week study tests different strategies for helping breast cancer survivors to modify their levels of sitting time. Participants will be assigned with equal likelihood to one of three groups (1) overall reduction in sitting time, (2) interruption of sitting time with standing breaks, and (3) usual care.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Re-Patterning Sitting Time Group
  • BEHAVIORAL Reducing Sitting Time Group

Trial Details

FieldValue
Enrollment Target 59 participants
Start Date 2015-11-30
Est. Completion 2018-01-24
Phase NA

Sponsor

University of Wisconsin, Madison

1,039 total trials

What the Registry Record Tells You About NCT02510430

The ClinicalTrials.gov registry entry for NCT02510430 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 59 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 3 interventions - of which Usual Care is the first listed.

NCT02510430 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02510430 about?

NCT02510430 is a clinical study titled "The Plan and Stand Study: Reducing Sitting Time in Breast Cancer Survivors". Excessive sitting time (sedentary time) has been associated with risk of insulin resistance and other factors which may be relevant to breast cancer prognosis. This 8-week study tests different strategies for helping breast cancer survivors to modify their levels of sitting time. Participants will b...

What is the current status of trial NCT02510430?

This trial is currently completed. It is a NA study. The enrollment target is 59 participants. The study started on 2015-11-30. Estimated completion is 2018-01-24.

What interventions are being tested in trial NCT02510430?

The interventions under investigation include: Usual Care (BEHAVIORAL), Re-Patterning Sitting Time Group (BEHAVIORAL), Reducing Sitting Time Group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02510430?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.